Scheduling and tracking software that makes sure each patient's cells come back to that patient, on time.
Platforms from Vineti (acquired by Ori Biotech 2023), TrakCel, Title21, and sponsors' own portals (Novartis CellChain, Kite Konnect, BMS Cell Therapy 360) coordinate slot booking, apheresis, courier pickup, manufacturing status, and infusion, with barcoded chain-of-identity. They are required by regulators for commercial autologous products and are a prerequisite for scaling to thousands of patients per year.
Orchestration software is a workflow engine with unique patient and product identifiers, integrations to hospital, courier, and manufacturing systems, and audit logs for regulators.
Nothing recorded yet: a foundation, or a gap to fill.
Dependencies are what this technology cannot be delivered without: manufacturing steps, instruments, software, upstream methods. See its full chain on the map.
Query for this technology: (TITLE:"Cell-therapy orchestration and chain-of-identity software" OR ABSTRACT:"Cell-therapy orchestration and chain-of-identity software") AND (cancer OR tumor OR tumour OR oncology OR carcinoma OR lymphoma OR leukemia OR leukaemia OR myeloma OR sarcoma OR melanoma OR glioma). Results are unfiltered search hits about Cell-therapy orchestration and chain-of-identity software, not a curated reading list.
Shares Cryopreservation and cell-therapy cold chain and the tag supporting.
Shares Cryopreservation and cell-therapy cold chain and the tag supporting.
Shares Cryopreservation and cell-therapy cold chain, CAR-T cell therapy and the tag supporting.
Shares Cryopreservation and cell-therapy cold chain, Autologous CAR-T manufacturing, batch by batch, CAR-T cell therapy and the tag supporting.
Shares Autologous CAR-T manufacturing, batch by batch and the tag supporting.
Shares Autologous CAR-T manufacturing, batch by batch and the tag supporting.
Shares Vein-to-vein time and manufacturing slots, Autologous CAR-T manufacturing, batch by batch, CAR-T cell therapy and the tag supporting.
Shares Vein-to-vein time and manufacturing slots, Autologous CAR-T manufacturing, batch by batch, CAR-T cell therapy and the tag supporting.